CJC-1295
About
About CJC-1295
A synthetic analog of growth hormone-releasing hormone (GHRH), this 30-amino acid peptide is modified with a drug affinity complex (DAC) that extends its half-life by binding to serum albumin. It stimulates pulsatile growth hormone secretion from the anterior pituitary by activating GHRH receptors. The compound has been investigated in clinical research for growth hormone deficiency and conditions associated with impaired GH/IGF-1 axis function.
Science
Mechanism of Action
CJC-1295 binds to the GHRH receptor on pituitary somatotroph cells, stimulating the synthesis and secretion of growth hormone. The DAC modification allows binding to albumin in the bloodstream, significantly extending the half-life. Downstream effects include increased hepatic IGF-1 production, enhanced protein synthesis, lipolysis, and improved cellular repair mechanisms.
Dosing
Typical Protocol
CJC-1295 with DAC: 1–2 mg once or twice weekly subcutaneously. CJC-1295 without DAC (Modified GRF 1-29): 100–300 mcg before bed, combined with Ipamorelin 100–300 mcg. Most protocols run for 3–6 month cycles with periodic IGF-1 monitoring. Administered subcutaneously, typically before sleep to align with natural GH pulsation.
⚠ Protocol information is for educational purposes only. Dosing must be determined by a licensed physician based on individual health status and goals.
Regulatory
Legal Status in 2026
This compound is legal to prescribe and dispense through a licensed 503A or 503B compounding pharmacy with a valid prescription. It is not FDA-approved as a finished drug product, but compounding is explicitly permitted under federal law. Quality and sterility standards vary by pharmacy — look for PCAB-accredited compounders.
Evidence
Evidence Tier
Evidence from randomized controlled trials (RCTs) or large observational studies in humans. This is the gold standard — effects have been measured in controlled conditions and results are peer-reviewed and reproducible.
Verified Providers Offering CJC-1295
Providers indexed by Vial with this compound in their formulary
PCAB-accredited Colorado compounding pharmacy with 33 years in hormone a…
Premium longevity-focused telehealth for hormones, peptides, and metabol…
PCAB-accredited compounding pharmacy specializing in hormones, peptides,…
Comprehensive hormone and longevity telehealth with elite-level lab moni…
Global PCAB-accredited pharmaceutical compounding group serving premium…
Florida-based hormone and wellness clinic with telehealth reach across 4…
Premium membership-based telehealth for hormones, peptides, and longevit…
LegitScript-certified telehealth for TRT, peptides, NAD+, and sexual hea…
Oregon-based hybrid longevity clinic integrating TRT, peptides, and rege…
DC-area hormone and peptide clinic with in-person care and nationwide te…
PCAB-accredited 503A/503B compounding pharmacy and the most-trusted part…
Physician-led peptide and hormone specialist with in-person care in CA a…
Peptide-focused telehealth for longevity, metabolic health, and sleep op…
PCAB-accredited compounding pharmacy with 27 years of experience in horm…
Telehealth-first men's hormone and metabolic health clinic in 30 states.